CVRx, Inc. - Common Stock, $0.01 par value (CVRX)

CUSIP: 126638105

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+61,362
Put/Call ratio
29%
SEC-reported price per share
$31.44
Number of holders
83
Value change
+$6,898,602
Number of buys
45
Open additional details 1 more signal available
Number of sells
31
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
26,612,903

Security key

126638105

Report period

Q4 2023

Institutions

83

Top holders

10

Ownership snapshot

Top reported holders of CVRX - CVRx, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Johnson & Johnson Innovat...
Disclosed value leader
Johnson & Johnson Innovat...
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $64,860,045 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Johnson & Johnson Innovation - JJDC, Inc. has the largest disclosed position value at $64.86M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Johnson & Johnson Innovation - JJDC, Inc.'s linked filing trail.
Disclosed position value Top 5
Johnson & Johnson Innovation - JJ... $64.86M
NEW ENTERPRISE ASSOCIATES 10 L P $37.59M
GSK plc $18.7M
NEA PARTNERS 10 L P $3.22M
JOHNSON & JOHNSON $53.03M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Johnson & Johnson Innovation - JJDC, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$64,860,045
3,495,575 shares
— 15 Sep 2023
NEW ENTERPRISE ASSOCIATES 10 L P
3/4/5
10%+ Owner
—
denominator unverified
$37,593,767
2,026,083 shares
— 02 Jul 2021
GSK plc
3/4/5
10%+ Owner
—
denominator unverified
$18,695,602
1,007,583 shares
— 02 Jul 2021
NEA PARTNERS 10 L P
3/4/5
10%+ Owner
—
denominator unverified
$3,217,197
173,388 shares
— 02 Jul 2021
JOHNSON & JOHNSON
13F
Company
13F
—
denominator unverified
$53,027,873
3,495,575 shares
— 30 Sep 2023
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$35,961,122
2,370,542 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
83
Shares
12,015,323
Rows available
83
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
64
Q4 2023 holders
83
Holder diff
19
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .